Arizona State Retirement System Incyte Corp Transaction History

Arizona State Retirement System

$15.3 Billion
Q1 2025

A detailed history of Arizona State Retirement System transactions in Incyte Corp stock. As of the latest transaction made, Arizona State Retirement System holds 47,372 shares of INCY stock, worth $3.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,372

Previous 47,516 0.3%

Holding current value

$3.19 Million

Previous $3.28 Million 12.59%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$60.0 - $75.26 $8,640 - $10,837	-144 Reduced 0.3%	47,372 $2.87 Million
Q4 2024 Feb 06, 2025	BUY	$65.08 - $83.38 $56,554 - $72,457	869 Added 1.86%	47,516 $3.28 Million
Q3 2024 Nov 12, 2024	BUY	$57.33 - $68.61 $200,884 - $240,409	3,504 Added 8.12%	46,647 $3.08 Million
Q2 2024 Aug 05, 2024	SELL	$51.18 - $63.75 $473,517 - $589,815	-9,252 Reduced 17.66%	43,143 $2.62 Million
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $2,544 - $2,996	45 Added 0.09%	52,395 $2.98 Million
Q4 2023 Jan 24, 2024	BUY	$52.16 - $64.19 $32,182 - $39,605	617 Added 1.19%	52,350 $3.29 Million
Q3 2023 Nov 06, 2023	BUY	$57.77 - $65.93 $635 - $725	11 Added 0.02%	51,733 $2.99 Million
Q2 2023 Aug 01, 2023	SELL	$60.95 - $75.51 $198,453 - $245,860	-3,256 Reduced 5.92%	51,722 $3.22 Million
Q1 2023 Apr 27, 2023	BUY	$70.23 - $86.01 $102,676 - $125,746	1,462 Added 2.73%	54,978 $3.97 Million
Q4 2022 Feb 07, 2023	BUY	$67.18 - $84.11 $122,334 - $153,164	1,821 Added 3.52%	53,516 $4.3 Million
Q3 2022 Nov 07, 2022	SELL	$66.18 - $82.86 $53,605 - $67,116	-810 Reduced 1.54%	51,695 $3.45 Million
Q2 2022 Jul 28, 2022	BUY	$66.18 - $83.18 $15,949 - $20,046	241 Added 0.46%	52,505 $3.99 Million
Q1 2022 May 04, 2022	BUY	$66.02 - $79.71 $76,385 - $92,224	1,157 Added 2.26%	52,264 $4.15 Million
Q4 2021 Feb 04, 2022	SELL	$63.34 - $74.11 $85,762 - $100,344	-1,354 Reduced 2.58%	51,107 $3.75 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $24,446 - $29,911	-356 Reduced 0.67%	52,461 $3.61 Million
Q2 2021 Aug 02, 2021	BUY	$79.87 - $87.53 $28,753 - $31,510	360 Added 0.69%	52,817 $4.44 Million
Q1 2021 May 06, 2021	SELL	$76.02 - $100.5 $89,627 - $118,489	-1,179 Reduced 2.2%	52,457 $4.26 Million
Q4 2020 Jan 28, 2021	SELL	$80.74 - $97.7 $206,371 - $249,721	-2,556 Reduced 4.55%	53,636 $4.67 Million
Q3 2020 Nov 05, 2020	BUY	$85.07 - $109.69 $1.1 Million - $1.42 Million	12,909 Added 29.82%	56,192 $5.04 Million
Q2 2020 Aug 04, 2020	BUY	$74.18 - $108.93 $768,801 - $1.13 Million	10,364 Added 31.48%	43,283 $4.5 Million
Q1 2020 May 05, 2020	SELL	$63.18 - $85.97 $41,130 - $55,966	-651 Reduced 1.94%	32,919 $2.41 Million
Q4 2019 Jan 27, 2020	BUY	$73.04 - $95.72 $17,456 - $22,877	239 Added 0.72%	33,570 $2.93 Million
Q3 2019 Oct 31, 2019	SELL	$72.82 - $86.52 $37,866 - $44,990	-520 Reduced 1.54%	33,331 $2.47 Million
Q2 2019 Jul 25, 2019	SELL	$73.52 - $88.7 $19,335 - $23,328	-263 Reduced 0.77%	33,851 $2.88 Million
Q1 2019 Apr 29, 2019	SELL	$63.56 - $88.17 $138,370 - $191,946	-2,177 Reduced 6.0%	34,114 $2.93 Million
Q4 2018 Jan 28, 2019	SELL	$58.5 - $69.94 $435,240 - $520,353	-7,440 Reduced 17.01%	36,291 $2.31 Million
Q3 2018 Oct 29, 2018	BUY	$61.75 - $74.23 $34,209 - $41,123	554 Added 1.28%	43,731 $3.02 Million
Q2 2018 Aug 07, 2018	SELL	$60.85 - $83.98 $24,644 - $34,011	-405 Reduced 0.93%	43,177 $2.89 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $66,448 - $80,784	-800 Reduced 1.8%	43,582 $3.63 Million
Q4 2017 Feb 09, 2018	SELL	$93.56 - $116.6 $1.69 Million - $2.1 Million	-18,042 Reduced 28.9%	44,382 $4.2 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $6.81 Million - $8.63 Million	62,424	62,424 $7.29 Million

Others Institutions Holding INCY

# of Institutions

697

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Incyte Corp Transaction History